PMDA — authorised 24 August 2022
- Marketing authorisation holder: Pfizer Japan Inc
- Status: approved
PMDA authorised Synarel on 24 August 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 24 August 2022.
Pfizer Japan Inc holds the Japanese marketing authorisation.